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ABSTRACT 
The solubility behavior of drugs remains one of the most exigent aspects in formulation development. With the advent of 
combinatorial chemistry and high throughput screening, the number of poorly water soluble compounds has dramatically increased.  
Among all the newly discovered chemical entities, about 40-45% drugs fail to reach market due to their poor water solubility. 
Because of solubility problem, bioavailability of drugs gets affected and hence solubility enhancement becomes necessary. Solid 
dispersions have attracted considerable interest as an efficient means of improving the dissolution rate and hence the bioavailability 
of drugs. Therefore, the application of this technique proves to be an important stratagem for pharmaceutical companies. However, 
the in - depth knowledge of the solid dispersion is desired for the scale up of formulation, from laboratory scale to industrial scale. 
There are various methods available to improve the solubility of the new drug in which solid dispersion emerged promising. A Solid 
dispersion generally composed of two components- the drug and the polymer matrix. Hence, this approach is expected to form a 
basis for the commercialization of many poorly water-soluble and water-insoluble drugs in their solid-dispersion formulations in the 
near future. This article reviews the various preparation techniques, carriers used, advantages and limitations of solid dispersions and 
compiles some of the recent advances. 
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INTRODUCTION 
Solubility is a significant physicochemical factor 
affecting absorption of drug and its therapeutic 
effectiveness. Formulation development would lead to 
be failure if drug having poor aqueous solubility. The 
venture to improve the solubility and dissolution of 
hydrophobic drugs remain one of the dificult tasks in 
drug development. Several methods have been 
introduced to triumph over this problem.
1
, 
2
 
Various methods to increase the solubility of drugs are 
available such as solid dispersion, self emulsifying drug 
delivery, Liquisolid techniques etc, in which drug in 
solution state or dissolved drug is adsorbed over 
insoluble carriers
 3-6
 
Model list of Essential Medicines of the World Health 
Organization (WHO) has assigned BCS 
(Biopharmaceutics Classification System) classification 
on the basis of data available in the public domain. Out 
of 130 orally administered drugs on the WHO list, 61 
could be classified with certainty.  
84% of these drugs belong to class I (highly soluble, 
highly permeable) 
17% to class II (poorly soluble, highly permeable)  
39% to class III (highly soluble, poorly permeable) and  
10% to class IV (poorly soluble, poorly permeable) 
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The term solid dispersion refers to a group of solid 
products consisting of at least two different components, 
a hydrophilic matrix and a hydrophobic drug. The drug 
can be dispersed molecularly, in amorphous particles 
(clusters) or in crystalline particles
7
. Pharmaceutical 
polymers are used to create this matrix and their 
selection is based on many factors, including 
physicochemi8al (e.g. drug–polymer miscibility and 
stability) and pharmacokinetic (e.g. rate of absorption) 
constraints
8
. Fig. 1 categorizes various possible 
categories of solid dispersions. The solid-dispersion 
components consist mainly of active pharmaceutical 
ingredients (API), the polymer, plasticizers, stabilizers, 
and other agents.  
Solid dispersion systems can increase dissolution rate 
and bioavailability of water insoluble drugs as when 
these are exposed to aqueous media, the carrier 
dissolves, and the drug is released as very fine colloidal 
particles. This greatly reduces particle size and increases 
surface area, which results in improved dissolution rates 
and per oral absorption. Furthermore, no energy is 
required to break up the crystal lattice of a drug during 
the dissolution process. Drug solubility and wettability 
may be increased by surrounding hydrophilic carriers 
9, 
10
 This approach has been used for a variety of poorly 
soluble drugs such as nimesulide, ketoprofen, 
tenoxicam, nifedipine, nimodipine, ursodeoxycholic 
acid, carbamazepine, celecoxib, carvedilol
5
 and 
albendazole.
11
 
Advantages of Solid Dispersion  
Solid dispersions are obtained by separate technological 
processes that are to disperse pharmacologically active 
component in a carrier or matrix in the solid state, in 
order to improve the solubility and increase the rate of 
dissolution, which, in turn, modulates the therapeutic 
action due to increased bioavailability
4, 12, 13
. They have 
also been used to increase the chemical stability of drugs 
in solution or suspension
14.
 
The first generation of SD was prepared employing 
crystalline carriers. These carriers include sugars and 
urea, which have in SD disadvantages crystal formation, 
which, being thermodynamically more stable, they do 
not release the drug with the desired speed
15
. 
Solid dispersions can be used as formulation vehicle to 
facilitate the preclinical safety and early clinical studies 
on new chemical entities with very low aqueous 
solubility. It provides a means to rapidly assess the 
safety and efficacy profile of the drug substance that 
may be otherwise difficult to obtain. 
Disadvantages of Solid Dispersion 
2, 4,16
 
Moreover, most of the polymers used in solid 
dispersions can absorb moisture, which may result in 
phase separation, crystal growth or conversion from the 
amorphous to the crystalline state or from a metastable 
crystalline form to a more stable structure during 
storage. This may result in decreased solubility and 
dissolution rate. demerits of solid dispersions is their 
poor scale-up for the purposes of manufacturing. 
 
MECHANISM OF SOLID DISPERSION 
The formulations of solid dispersions results into 
reduction in particle size, improved wettability and 
enhancement of the dispersibility of the drug, thereby 
markedly improving the dissolution rate. The suggested 
mechanism behind this tremendous increase in 
dissolution rate may include:
17
  
 Partial transformation of crystalline drug to the 
amorphous state or altering the crystalline 
morphology  
 Formation of solid solution  
 Formation of complexes  
 Intimate mixing of the drug with hydrophilic 
excipients  
 Reduction of aggregation and agglomeration  
 Improved wetting of the drug and solubilization of 
drug by the carrier at the diffusion layer. 
TYPES OF SOLID DISPERSIONS 
Eutectic mixtures 
18, 19
 
A simple eutectic mixture consists of two compounds 
which are completely miscible in the liquid state but 
only to a very limited extent in the solid state. It is 
prepared by rapid solidification of fused melt of two 
components that show complete liquid miscibility but 
negligible solid-solid solution 
Amorphous precipitation in crystalline matrix 
20, 21
 
This is similar to simple eutectic mixtures but only 
difference is that drug is precipitated out in an 
amorphous form. 
Solid solution 
22
 
Solid solutions are comparable to liquid solutions, 
consisting of just one phase irrespective of the number 
of components. In the case of solid solutions, the drug's 
particle size has been reduced to its absolute minimum 
viz. the molecular dimensions and the dissolution rate is 
determined by the dissolution rate of the carrier. 
Classified according to their miscibility (continuous 
versus discontinuous solid solutions) or second, 
according to the way in which the solvate molecules are 
distributed in the solvendum (substitutional, interstitial 
or amorphous). 
Continuous solid solutions 
In a continuous solid solution, the components are 
miscible in all proportions. Theoretically, this means 
that the bonding strength between the two components 
is stronger than the bonding strength between the 
molecules of each of the individual components. Solid 
solutions of this type have not been reported in the 
pharmaceutical world till date. 
Discontinuous solid solutions 
22
 
In the case of discontinuous solid solutions, the 
solubility of each of the components in the other 
component is limited. Due to practical considerations, it 
has been suggested by Goldberg et al. that the term 
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`solid solution' should only be applied when the mutual 
solubility of the two components exceeds 5%. 
Substitutional solid dispersions 
23
 
Substitution is only possible when the size of the solute 
molecules differs by less than 15% or so from that of the 
solvent molecules. Classical solid solutions have a 
crystalline structure, in which the solute molecules can 
either substitute for solvent molecules in the crystal 
lattice or fit into the interstices between the solvent 
molecules. 
Interstitial solid solutions 
24, 25
 
In interstitial solid solutions, the dissolved molecules 
occupy the interstitial spaces between the solvent 
molecules in the crystal lattice. Solute molecule 
diameter should be less than 0.59 times than that of 
solvent molecular diameter. 
 
 
Figure 1: Categories of solid dispersion 
2
 
 
METHODS OF SOLID DISPERSION 
Various methods have been developed for preparation of 
solid dispersions, these methods deal with the challenge 
of mixing a matrix and a drug, preferably on a molecular 
level, while matrix and drug are generally poorly 
miscible. During many of the preparation techniques, 
demixing (partially or complete), and formation of 
different phases is observed. Phase separations like 
crystallization or formation of amorphous drug clusters 
are difficult to control and therefore unwanted.  
The brief description of the methods is as follows: 
Kneading Method  
In this method, the polymer and drug are mixed by 
geometric dilution. The mixture is malaxada with 
adding the amount of solvent minina (equivalent to 30% 
of the post of weight) in order to obtain a moist 
consistency. Industrially, a mixture of components is 
performed in a malaxadora, and in this case, required 
some adjustments in the methodology used, initially at 
the level bench, which can cause some modifications of 
the physical and chemical characteristics and 
pharmacotechnical the product. The drying of the 
material can be done in an oven or directly in 
malaxadora followed by pulverization to standardize the 
size particle. Due to the simplicity, the high throughput 
and the scale transposition facility, this method is the 
most widely used in the pharmaceutical industry
26
. 
 
Solvent melting method  
Accurately weighed drug is dissolved in organic solvent. 
The solution is incorporated into the melt of mannitol 
and cooled suddenly and mass is kept in desiccator for 
complete drying. The solidified mass is crushed, 
pulverized and passed through sieve. This technique 
possesses unique advantages of both the fusion and 
solvent evaporation methods. From a practical 
standpoint, it is only limited to drugs with a low 
therapeutic dose (less than 50 mg).
27 
Spray-Drying Method 
Drug is dissolved in suitable solvent and the required 
amount of carrier is dissolved in water. Solutions are 
then mixed by sonication or other suitable method to 
produce a clear solution, which is then spray dried using 
spray dryer.
28 
Method supercritical fluid  
The process of supercritical fluid has emerged as an 
alternative method to the solvent method, forming small 
particle size precipitation and low organic matter 
content, with also better flow. Powder flowability is 
important when commercialization of the process is 
desired
35
. Carbon dioxide is currently We used this 
technique due to the advantages associated with its use, 
as a non - toxic gas, non - flammable, inexpensive and 
low critical temperature, making it attractive in the 
processing of heat sensitive drugs and the process 
solvent removal extremely controlled
13
. Although the 
results promising described in the literature, is a 
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technique still Experimental and having an initial cost 
very high
29
.  
Co-grinding method 
Physical mixture of drug and carrier is mixed for some 
time employing a blender at a particular speed. The 
mixture is then charged into the chamber of a vibration 
ball mill steel balls are added. The powder mixture is 
pulverized. Then the sample is collected and kept at 
room temperature in a screw capped glass vial until use. 
Ex. chlordiazepoxide and mannitol solid dispersion was 
prepared by this method.
30
 
Gel entrapment technique 
Hydroxyl propyl methyl cellulose is dissolved in organic 
solvent to form a clear and transparent gel. Then drug 
for example is dissolved in gel by sonication for few 
minutes. Organic solvent is evaporated under vacuum. 
Solid dispersions are reduced in size by mortar and 
sieved.
31
 
Melting /Fusion method 
This process involves the formulation of physical 
mixture of a active ingredients and a water soluble 
carrier and heating it directly until it melted. The melted 
mixture is then solidified rapidly in an ice-bath under 
vigorous stirring. The final solid mass is crushed, 
pulverized and sieved. The modification in the method 
can be done by pouring the homogenous melt in the 
form of a thin layer onto a ferrite plate or a stainless 
steel plate and cooled by flowing air or water on the 
opposite side of the plate. In addition, a super-saturation 
of a solute or drug in a system can often be obtained by 
quenching the melt rapidly from a high temperature. 
Under such conditions, the solute molecule is arrested in 
the solvent matrix by the instantaneous solidification 
process. The quenching technique gives a much finer 
dispersion of crystallites when used for simple eutectic 
mixtures
32, 
33
. Advantage of melting method is that it is 
economic and solventless process, however this method 
is not suitable for the drug or carrier which is unstable at 
fusion temperature or evaporates at higher temperature.  
Solvent evaporation method 
In this method, the physical mixture of the drug and 
carrier is dissolved in a common solvent, which is 
evaporated until a clear, solvent free film is left. The 
film is further dried to constant weight. The main 
advantage of the solvent method is thermal 
decomposition of drugs or carriers can be prevented 
because of the relatively low temperatures required for 
the evaporation of organic solvents 
34
. 
CHARACTERIZATION OF SOLID 
DISPERSIONS 
Different molecular structures of the drug in the matrix 
can be encountered in solid dispersions. Many 
techniques have been available to investigate the 
molecular arrangement in solid dispersions. However, 
most effort has been put into differentiate between 
amorphous and crystalline material. Many techniques 
are available which detect the amount of crystalline 
material in the dispersion
35 
Drug -carrier miscibility:  
It is carried out by DSC, X-ray diffraction
36
 and NMR 
1H Spin lattice relaxation time 
Drug carrier interactions:  
It is carried out by FT-IR spectroscopy, Solid state 
NMR and Raman spectroscopy 
Physical Structure:  
It characterized by following techniques; 
Surface area analysis 
Surface properties 
Scanning electron microscopy 
Dynamic vapor sorption 
Raman microscopy 
Inverse gas chromatography 
Amorphous content: 
This study performed by the DSC, Powder X-ray 
diffraction, Polarised light optical microscopy and Hot 
stage microscopy 
Dissolution enhancement
37
: 
Solubility enhancement by the solid dispersion was 
examined by help of following parameters; 
 Dissolution 
 Intrinsic dissolution 
 Dynamic solubility 
 Dissolution in bio-relevant media 
Temperature Modulated Differential Scanning 
Calorimetry (TMDSC) 
Temperature Modulated Differential Scanning 
Calorimetry (TMDSC) can be used to assess the degree 
of mixing of an incorporated drug. 
38
 
Stability: 
Stability of the solid dispersion was studied by 
Isothermal Calorimetry, DSC (Tg, Temperature 
recrystallization) and Saturated solubility studies 
Water vapour sorption 
Water vapour sorption can be used to discriminate 
between amorphous and crystalline material when the 
hygroscopicity is different. This method requires 
accurate data on the hygroscopicity of both completely 
crystalline and completely amorphous samples.
39 
Isothermal Microcalorimetry 
Isothermal microcalorimetry measures the 
crystallization energy of amorphous material that is 
heated above its glass transition temperature (Tg) . This 
technique has some limitations. Firstly, this technique 
can only be applied if the physical stability is such that 
only during the measurement crystallization takes place. 
Secondly, it has to be assumed that all amorphous 
material crystallizes. 
40 
Mankar et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2018; 8(5):44-49           
ISSN: 2250-1177                                                                               [48]                                                                             CODEN (USA): JDDTAO 
APPLICATIONS OF SOLID DISPERSION
41, 42
 
Solid dispersion systems can provide numerous 
additional benefits; some of them are as follows: 
1. To increase the solubility of poorly soluble drugs 
thereby increase the dissolution rate, absorption and 
bioavailability. 
2. To stabilize unstable drugs against hydrolysis, 
oxidation, recrimination, isomerization, photo-oxidation 
and other decomposition procedures. 
3. To reduce a side effect of certain drugs. 
4. Masking of unpleasant taste and smell of drugs. 
5. Improvement of drug release from ointment creams 
and gels. 
6. To avoid undesirable incompatibilities. 
7. To obtain a homogeneous distribution of a small 
amount of drug in solid state. 
8. To dispense liquid (up to 10%) or gaseous 
compounds in a solid dosage. 
9. To formulate a fast release primary dose in a 
sustained released dosage form. 
10. To formulate sustained release regimen of soluble 
drugs by using poorly soluble or insoluble carriers. 
11. To reduce pre-systemic inactivation of drugs like 
morphine and progesterone 
CONCLUSION  
The enhancement solubility of poorly water soluble 
drugs remains one of the most challenging aspects of 
drug development. Solubilization of drug is the rate 
determining step for oral absorption of drugs, which can 
subsequently affect the in vivo absorption of drug. 
Because of solubility problem of many drugs the 
bioavailability of these gets affected and hence 
solubility enhancement becomes necessary. Solid 
dispersions are one of the most attractive processes to 
improve drug’s poor water solubility. Various solubility 
enhancers like water-soluble carriers, co solvents, 
surfactants and superdisintegrants via solid dispersion 
approach (fusion method and solvent evaporation 
method) aids in solubility enhancement. These 
significantly help to improve the bioavailability and 
bioequivalence
 
REFERENCES 
1. Leuner C, Dressman J. Improving drug solubility for oral 
delivery using solid dispersions. Eur J Pharm Biopharm 2000; 
50:47-60.. I 
2. Dalvi P., Gerange A., Ingale P. Solid dispersion: strategy to 
enhance solubility. Journal of Drug Delivery and 
Therapeutics, 2015; 5(2):20-28. 
https://doi.org/10.22270/jddt.v5i2.1060NT 
3. Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR, Barzegar-
Jalali M. The effect of type and concentration of vehicles on 
the dissolution rate of a poorly soluble drug (indomethacin) 
from liquisolid compacts. J Pharm Pharm Sci 2005;8:18-25.R 
4. Bhirud Y., Phalak H. Advances in solid dispersion technology 
and its applications in the development of solid dosage 
forms. Journal of Drug Delivery and Therapeutics, 2016; 
6(6):40-47. https://doi.org/10.22270/jddt.v6i6.1316 
5. Zoghbi A., Wang B. Carvedilol solubility enhancement by 
inclusion complexation and solid dispersion: review. Journal 
of Drug Delivery and Therapeutics, 2015; 5(2):1-8. 
https://doi.org/10.22270/jddt.v5i2.1074 
6. Khan AD, Singh L, Various techniques of bioavailability 
enhancement: a review, Journal of Drug Delivery & 
Therapeutics. 2016; 6(3):34-41. 
https://doi.org/10.22270/jddt.v6i3.1228 
7. Dhirendra K. Solid dispersions: A review. Pak J Pharm Sci 
2009; 22(2):234-246.  
8. Doney J, Yang J, Baer H, Draganoiu E. Excipients in 
polymeric Drug Delivery and formulations. Pharm Tech. 
2008:96-98.  
9. Kerns EH, Li D. Drug-like properties: Concepts, structure, 
design and methods from ADME to toxicity optimization. 
Academic Press. 2008: 461.  
10. Kalyanwat R, Patel S. Solid dispersion: A method for 
enhancing drug dissolution International Journal of Drug 
Formulation & Research. Nov-Dec. 2010, Vol. 1 (iii):1-14.  
11. Chiou WL, Riegelman S. Pharmaceutical application of solid 
dispersion system. J Pharm Sci 1971; 60:1281-1302.  
12. Janssens S, de Armas HN, D’Autry W, Van Schepdael A, Van 
den Mooter G, Characterization of ternary solid dispersions of 
Itraconazole in polyethylene glycol 6000/polyvidone-
vinylacetate 64 blends, European journal of pharmaceutics and 
biopharmaceutics,  2008, 69(3), 1114-20. 
13. Sareen S, Mathew G, Joseph L, Improvement in solubility of 
poor water-soluble drugs by solid dispersion, International 
journal of pharmaceutical investigation,  2012, 2(1), 12. 
14. Sethia S, Squillante III E, Solid dispersions: revival with 
greater possibilities and applications in oral drug delivery, 
Critical Reviews™ in Therapeutic Drug Carrier Systems,  
2003, 20(2&3). 
15. Vasconcelos T, Sarmento B, Costa P, Solid dispersions as 
strategy to improve oral bioavailability of poor water soluble 
drugs, Drug discovery today,  2007, 12(23), 1068-75. 
16. Babu PS, Chowdary KPR. Enhancement of dissolution rate of 
celecoxib by solid dispersion in superdisintegrants. Ind Drugs. 
2008; 45(7):547-552.  
17. Kalyanwat R, Patel S. Solid dispersion: A method for 
enhancing drug dissolution. Int J Drug Form Res. 2010; 
1(3):1-14. 
18. Sekiguchi K, Obi N. Studies on the absorption of eutectic 
mixture. I. A comparison of the behaviour of a eutectic 
mixture of sulfathiazole and that of ordinary sulfathiazole in 
man. Chem Pharm Bull 1961;9:866-72. 
19. Goldberg AH, Gibaldi M, Kanig JL. Increasing dissolution 
rates and gastrointestinal absorption of drugs via solid 
solutions and eutectic mixtures II-experimental evaluation of a 
eutectic mixture: urea-acetaminophen system. J PharmaSci 
1966;55:482-7. 
20. Castellan GW. Physical Chemistry, Addison-Wesley, Menlo 
Park, CA; 1983. p. 324-36. 
21. Swarbrick J. ed 3. Encyclopaedia of pharmaceutical 
technology; 2006. p. 775-7. 
22. Goldberg AH, Gibaldi M, Kanig JL. Increasing dissolution 
rates and gastrointestinal absorption of drugs via solid 
solutions and eutectic mixtures. I. Theoretical considerations 
and discussion of the literature. J Pharm Sci 1965;54:1145-8. 
23. Hume Rotherly W, Raynor GV. The structure of metals and 
alloys, Institute of Metals, London; 1954. 
24. Argade PS, Magar DD, Saudagar RB. Review article on solid 
dispersion as solubility enhancement technique for poorly 
water soluble drugs. J Adv Pharm Edu Res 2013;3:427-39. 
25. Verma S., Patel U., Patel R. Formulation and evaluation of 
ivermectin solid dispersion. Journal of Drug Delivery and 
Mankar et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2018; 8(5):44-49           
ISSN: 2250-1177                                                                               [49]                                                                             CODEN (USA): JDDTAO 
Therapeutics, 2017; 7(7):15-17. 
https://doi.org/10.22270/jddt.v7i7.1572 
26. Modi A, Tayade P, Enhancement of dissolution profile by 
solid dispersion (kneading) technique, AAPS PharmSciTech,  
2006, 7(3), E87-E92 
27. Patel MM, Patel DM. Fast dissolving valdecoxib tablets 
containing solid dispersion of valdecoxib. Ind J Pharm Sci. 
2006: 222-225.  
28. Bakatselou V, Oppenheim RC, Dressman JB. Solubilization 
and wetting effects of bile salts on the dissolution of steroids. 
Pharm Res, 1991; 8:1461-9. 
29. Al-Marzouqi AH, Jobe B, Dowaidar A, Maestrelli F, Mura P, 
Evaluation of supercritical fluid technology as preparative 
technique of benzocaine–cyclodextrin complexes—
Comparison with conventional methods, Journal of 
pharmaceutical and biomedical analysis,  2007; 43(2):566-74. 
30. Nokhodchi A, Talari R, Valizadeh H, Jalali MB. An 
Investigation on the Solid Dispersions of Chlordiazepoxide. 
International Journal of Biomedical Science 2007; 3(3):210-
16. 
31. Bhise SB, Rajkumar M. Effect of HPMC on Solubility and 
Dissolution of Carbamazepine Form III in Simulated 
Gastrointestinal Fluids. Asian Journal of Pharmaceutics 2008; 
2(1):38-42. 
32. Goldberg A, Gibaldi M, Kanig JL. Increasing dissolution rates 
and gastrointestinal absorption of drugs via solid solutions and 
eutectic mixtures III - experimental evaluation of griseofulvin- 
succinic acid solid solution. J Pharm Sci. 1966; 55:487-492.  
33. Kalaiselvan R, Mohanta GP, Manna PK, Manavalan R. 
Studies on mechanism of enhanced dissolution of albendazole 
solid dispersions with crystalline carriers. Ind J Pharm Sci. 
2006; 68:599-607.  
34. Serajuddin A., Solid dispersion technique. J. Pharmaceut. Sci., 
1999; 88(10):891-900. 
35. Kaushal A.M, Guptam P., Bansal AK., Amorphous drug 
delivery systems: molecular aspects, design, and performance. 
Crit. Rev. There. Drug Carrier Syst., 2004; 21(3):133-193.  
36. Taylor L.S., Zografi G., Spectroscopic characterization of 
interactions between PVP and indomethacin in amorphous 
molecular dispersions. Pharmaceut. Res., 1997; 14:1691-1698.  
37. Cilurzo F., Minghetti P., Casiraghi A., Montanari L., 
Characterization of nifedipine solid dispersions. Int. J. 
Pharmaceut., 2002; 242(1-2):313-317. 
38. Pikal M.J., Lukes A.L., Lang J.E., Gaines K. Quantitative 
crystallinity determinations for beta-lactam antibiotics by 
solution calorimetry: correlations with stability. J. Pharmaceut. 
Sci., 1978; 67(6):767-73.  
39. Buckton G., Darcy P., The use of gravimetric studies to assess 
the degree of crystallinity of predominantly crystalline 
powders. Int. J. Pharmaceut., 1995; 123:265-271.  
40. Sebhatu T., Angberg M., Ahlneck C., Assessment of the 
degree of disorder in crystalline solids by isothermal 
microcalorimetry. Int, J. Pharmaceut., 1995; 104:135-144. 
41. Shende M., Fiske P. Fabrication and optimization of novel 
glipizide sustained release matrices for solubility and 
dissolution enhancement by solid dispersion through 
hydrophillic carriers. Journal of Drug Delivery and 
Therapeutics, 2017; 7(6):38-48. 
https://doi.org/10.22270/jddt.v7i6.1538 
42. Nagasamy V.D.RA., Saraswathi S., Padma Priya M., Khan N. 
I., Kathirulla N., Sruthi S. Dissolution enhancement of 
diacerein using water soluble carrier by solid dispersion 
technology. Journal of Drug Delivery and Therapeutics, 2017; 
7(5):33-41. https://doi.org/10.22270/jddt.v7i5.1503
 
 
